March, 2017, CDSCO issued the renewal registration certificate for our API product, Clarithromycin. The renewal certificate is valid for three years. In the meanwhile, approval of 5-year shelf life extension was obtained and the product becomes more competitive. Since 2008, Clarithromycin has obtained the registration certificate from India. With the improvement of company's production and quality management level as well as over 10 years of experience in India market, the share of our product in India market is generally going upward. As a drug manufacturer, we will continuously assure the quality of our products and improve our management level with no spare effort.